{
    "2021-09-22": [
        [
            {
                "time": "",
                "original_text": "贝达药业股权激励争议",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股权激励",
                        "争议"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)股东凯铭投资质押580万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "质押",
                        "580万股"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：股东凯铭投资累计质押股数为3781万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "累计质押",
                        "3781万股"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：人工关节拟中标结果好于预期 市场紧张情绪得到缓解",
                "features": {
                    "keywords": [
                        "医药生物",
                        "人工关节",
                        "中标结果",
                        "市场情绪",
                        "缓解"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：把握景气度持续向上板块和个股估值修复机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "景气度",
                        "估值修复",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}